New Product

Asthma is a long-term condition characterised by paroxysmal and reversible obstruction of the airways, whereas Chronic Obstructive Pulmonary Disease (COPD) is a chronic, not fully reversible [...]

High Dose Antipsychotic Treatment (HDAT) is a term many of us are familiar with but are you confident in it’s use, need and subsequent monitoring requirements? Are the multidisciplinary team [...]

Advance planning for flu vaccination clinics has become an important part of patient care. The flu vaccination delivered in the following year provides vulnerable patients with protection against [...]

Cariprazine (Reagila) is a new second-generation antipsychotic which is licensed to treat schizophrenia in adults (over 18 years). It is only available as an oral capsule and is presented in [...]

A new formulation of clozapine will be available from June 2019 consisting of an oral dispersible tablet marketed as Zaponex orodispersible tablets by the company Leyden Delta BV. The special [...]

The British Standards Institute (BSI) has undertaken a review of the contents of first aid kits and updated them to a new British standard specification (BS 8599–1:2019). The standard has been [...]

Buprenorphine has been long-established as an opioid substitution medication available as sublingual tablets. It is an opioid partial agonist/antagonist with strong receptor binding affinity and [...]

Nyxoid (naloxone nasal spray) is a novel formulation of naloxone, which is used for the emergency treatment of a patient who has a suspected opioid overdose. The single-use spray is administered [...]

The method for prescribing and administering medication in hospitals has largely stayed the same for the last 40 years with the use of paper prescription charts. However, the number and [...]

Smoking is the main cause of preventable illness and premature death. It is the primary reason for the gap in healthy life expectancy between rich and poor, and rates of smoking by people with [...]